- Corporate Officers - M
- Milano Vincent
Insider Trading History of Milano Vincent
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Milano Vincent since 2016.
This trader's CIK number is 1187159.
At the time of last reporting, Milano Vincent was the Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
Note that in the past
MILANO VINCENT also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Aceragen, Inc. (ACGN) by Milano Vincent
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ACGN | 0 | $0 | 3,283 | $1,749 | 0 | $0 |
| 2021 | ACGN | 0 | $0 | 5,950 | $24,174 | 0 | $0 |
| 2020 | ACGN | 0 | $0 | 40,175 | $165,882 | 0 | $0 |
| 2018 | ACGN | 25,000 | $99,020 | 0 | $0 | 0 | $0 |
| 2016 | ACGN | 40,000 | $78,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Spark Therapeutics, Inc. (ONCE) by Milano Vincent
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ONCE | 0 | $0 | 0 | $0 | 1,500 | $0 |
| 2018 | ONCE | 0 | $0 | 0 | $0 | 1,500 | $0 |
Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Milano Vincent
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ACRS | 0 | $0 | 0 | $0 | 4,793 | $0 |
| 2024 | ACRS | 0 | $0 | 0 | $0 | 4,660 | $0 |
| 2023 | ACRS | 0 | $0 | 0 | $0 | 4,507 | $0 |
| 2022 | ACRS | 0 | $0 | 0 | $0 | 3,356 | $0 |
Yearly summary of insider trading at Biocryst Pharmaceuticals Inc (BCRX) by Milano Vincent
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | BCRX | 15,000 | $93,750 | 0 | $0 | 0 | $0 |
| 2021 | BCRX | 7,500 | $91,425 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Milano Vincent:
1. Aceragen, Inc. (ACGN)
2. Spark Therapeutics, Inc. (ONCE)
3. Aclaris Therapeutics, Inc. (ACRS)
4. Biocryst Pharmaceuticals Inc (BCRX)
Table 1. Insider trading of Aceragen, Inc. (ACGN) by Milano Vincent
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-10 | ACGN | Sale | 3,283 | .53 | 1,749 |
| 2021-01-12 | IDRA | Sale | 3,210 | 4.20 | 13,475 |
| 2021-01-05 | IDRA | Sale | 2,740 | 3.90 | 10,699 |
| 2020-12-22 | IDRA | Sale | 37,169 | 4.32 | 160,532 |
| 2020-01-07 | IDRA | Sale | 3,006 | 1.78 | 5,350 |
| 2018-12-24 | IDRA | Buy | 15,000 | 2.93 | 43,920 |
| 2018-08-07 | IDRA | Buy | 10,000 | 5.51 | 55,100 |
| 2016-03-15 | IDRA | Buy | 40,000 | 1.97 | 78,800 |
Table 2. Insider trading of Spark Therapeutics, Inc. (ONCE) by Milano Vincent
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-30 | ONCE | Option Ex | 1,500 | .00 | 0 |
| 2018-05-31 | ONCE | Option Ex | 1,500 | .00 | 0 |
Table 3. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Milano Vincent
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-06 | ACRS | Option Ex | 4,793 | .00 | 0 |
| 2024-06-01 | ACRS | Option Ex | 4,660 | .00 | 0 |
| 2023-06-02 | ACRS | Option Ex | 4,507 | .00 | 0 |
| 2022-06-03 | ACRS | Option Ex | 3,356 | .00 | 0 |
Table 4. Insider trading of Biocryst Pharmaceuticals Inc (BCRX) by Milano Vincent
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-05-20 | BCRX | Buy | 15,000 | 6.25 | 93,750 |
| 2021-11-24 | BCRX | Buy | 7,500 | 12.19 | 91,425 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Milano Vincent
(Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.